Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$558,280
+$351,383 QoQ
Shares Held
426,169
+225.4% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 130 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Derivatives in LCTX

reported options exposure · as of Jun 30, 2026
CallValue
$51,614
CallShares
39,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. LCTX ranks #261 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in LCTX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $558,280 426,169
2026-06-30 $51,614 39,400
2026-03-31 $55,774 35,300
2026-03-31 $206,897 130,948
2025-12-31 $20,875 12,500
2025-12-31 $23,714 14,200
2025-12-31 $846,776 507,052
2025-09-30 $199,420 118,000
2025-09-30 $35,321 20,900
2025-09-30 $327,805 193,968
2025-06-30 $214,214 235,400
2025-06-30 $168,787 185,481
2025-03-31 $1,350 3,000
2025-03-31 $21,767 48,372
2025-03-31 $3,600 8,000
2024-12-31 $65,887 131,775
2024-12-31 $2,500 5,000
2024-09-30 $910 1,000
2024-09-30 $58,058 63,800
2024-06-30 $400 400
2024-06-30 $31,300 31,300
2024-03-31 $31,672 21,400
2024-03-31 $327,405 221,220
2023-12-31 $981 900
2023-12-31 $640,297 587,429
2023-12-31 $3,597 3,300
2023-09-30 $18,644 15,800
2023-09-30 $468,380 396,933
2023-06-30 $7,191 5,100
2023-06-30 $705 500
2023-06-30 $569,174 403,670
2023-03-31 $372,945 248,630
2023-03-31 $750 500
2023-03-31 $34,950 23,300
2022-12-31 $150,035 128,236
2022-12-31 $1,755 1,500
2022-12-31 $19,305 16,500
2022-09-30 $138,759 122,796
2022-06-30 $54,576 34,542
2022-03-31 $42,504 27,600
2022-03-31 $20,636 13,400
2022-03-31 $86,244 56,003
2021-12-31 $122,255 49,900
2021-12-31 $34,055 13,900
2021-12-31 $590,434 240,994
2021-09-30 $37,296 14,800
2021-09-30 $181,077 71,856
2021-09-30 $210,168 83,400
2021-06-30 $211,766 74,304
2021-06-30 $75,525 26,500